Corpus 1,280 assessed · 1,181 scored · 646 reproduced ≥75 · 170 flagged ·∅ 74/100

Publications 2 Datasets 392.5k Experiments 5k

Explore

Filters: 2 ✕ whole-exome sequencing (wes) ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104). PMID 38897205	Cell Rep Med	2024	72	L1 72/100
TOSCA: an automated Tumor Only Somatic CAlling workflow for somatic mutation detection without matched normal samples. PMID 36699358	Bioinform Adv	2022	50	L1 50/100

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).

PMID 38897205 · Cell Rep Med · 2024

L1 72/100

TOSCA: an automated Tumor Only Somatic CAlling workflow for somatic mutation detection without matched normal samples.

PMID 36699358 · Bioinform Adv · 2022

L1 50/100